Jordan Pinsker, MD (Ret)
Jordan E Pinsker, MD (Ret), Lieutenant Colonel, Army

Name: Jordan E Pinsker, MD (Ret), Lieutenant Colonel, Army
Research Interests:
Automated Insulin Delivery
Clinical Decision Support Systems for Diabetes
Education
- Union College, Schenectady, NY, 1994 – 1998
- Albany Medical College, Albany, NY, 1997 – 2001
Internship: Pediatrics, Brooke Army Medical Center, San Antonio, TX, 2001 – 2002
Residency: Pediatrics, Brooke Army Medical Center, San Antonio, TX, 2002 – 2004
Fellowship: Pediatric Endocrinology, National Capital Consortium, Washington, DC, 2004 – 2007
Biography
As I am board certified in Clinical Informatics, Pediatric Endocrinology and General Pediatrics, I aim to use my skills in technology and medicine to promote cross-disciplinary scientific advancement in developing advanced technological care for persons with diabetes.
Representative publications, projects, and/or deployments
- Ongoing Research Support and Recent Military Awards:
- Insulet #G190270. 11/25/2019 – Present. Evaluating the Safety and Effectiveness of the Omnipod Horizon™ Automated Glucose Control System in Patients with Type 1 Diabetes. Role: Co-Investigator
- Medtronic #CEP304. 01/24/2019 – Present. Multi-center, Randomized Controlled Trial in Adult and Pediatric Patients with Type 1 Diabetes Using Hybrid Closed Loop System and Control (CSII, MDI and SAP) at Home. Role: Site PI
- NIH R01 #DK120358. 09/30/2018 - 05/31/2021. Automated Glucose Regulation to improve Diabetes Control and Outcomes for Pregnant Women with Type 1 Diabetes and Fetus. Role: Co-Investigator
- Helmsley Charitable Trust #2018PG-TID061. 04/01/2018 - 03/31/2021. Development of Microneedle-based Sensor to Enhance Automated Insulin Delivery. Role: Co-Investigator
- JDRF #2-SRA-2017-503-M-B. 08/01/2017 - 03/31/2021. Harnessing Non-Glucose Feedback Signals for Automatic Glucose Control in Type 1 Diabetes: Confronting Exercise-Safety and Stress-Aware Control. Role: Co-PI
- NIH UC4 #DK108483. 01/01/2016 - 12/31/2020. Clinical Acceptance of the Artificial Pancreas: The International Diabetes Closed Loop Trial. Role: Co-Investigator
- 2019: AMEDD Distinguished Member of the Regiment (DMOR)
- 2018: Order of Military Medical Merit (O2M3)
- 2017: The Surgeon General's Physician Recognition Award for Army National Guard Lieutenant Colonel
Bibliography
- 1. Pinsker JE, Singh H, McElwee Malloy M, Constantin A, Leas S, Kriegel K, Habif S. A Virtual Training Program for the Tandem t:slim X2 Insulin Pump: Implementation and Outcomes. Diabetes Technol Ther. 2021; PMID: 33439754
- 2. Pinsker JE, Muller L, Constantin A, Leas S, Manning M, McElwee Malloy M, Singh H, Habif S. Real-World Patient Reported Outcomes and Glycemic Improvements with Initiation of Control-IQ Technology. Diabetes Technol Ther. 2021; PMID: 32846114
- 3. Pinsker JE, Deshpande S, McCrady-Spitzer S, Church M, Kaur R, Perez J, Desjardins D, Piper M, Reid C, Doyle III FJ, Kudva YC, Dassau E. Use of the Interoperable Artificial Pancreas System (iAPS) for Type 1 Diabetes Management During Psychological Stress. J Diabetes Sci Technol. 2021; 15(1):184-185. PMID: 32783473
- 4. Wolkowicz KL, Aiello EM, Vargas E, Teymourian H, Therani F, Wang J, Pinsker JE, Doyle III FJ, Patti M, Laffel LM, Dassau E. A Review of Biomarkers in the Context of Type 1 Diabetes: Biological Sensing for Enhanced Glucose Control. Bioeng Transl Med. 2021; e10201. DOI: 10.1002/btm2.10201
- 5. Isganaitis E, Raghinaru D, Ambler-Osborn L, Pinsker JE, Buckingham BA, Wadwa RP, Ekhlaspour L, Kudva YC, Levy CJ, Forlenza GP, Beck RW, Kollman C, Lum JS, Brown SA, Laffel LM, for the iDCL Trial Research Group. Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop (iDCL) Trial. Diabetes Technol Ther. 2021; PMID: 33216667
- 6. O’Malley G, Messer L, Levy CJ, Pinsker JE, Forlenza GP, Isganaitis E, Kudva YC, Ekhlaspour L, Raghinaru D, Lum J, Browns SA, for the iDCL Trial Research Group. Clinical Management and Pump Parameter Adjustment of the Control-IQ Closed-loop Control System: Results from a 6-month Multicenter Randomized Clinical Trial. Diabetes Technol Ther. 2021; PMID: 33155824
- 7. Pinsker JE, Leas S, Muller L, Habif S. Real World Improvements in Hypoglycemia in an Insulin-Dependent Cohort with Diabetes Mellitus Pre/Post Tandem Basal-IQ Technology Remote Software Update. Endocr Pract. 2020; 26(7):714-721. PMID: 32160040
- 8. Brown SA, Beck RW, Raghinaru D, Buckingham BA, Laffel LM, Wadwa RP, Kudva YC, Levy CJ, Pinsker JE, Dassau E, Doyle III FJ, Ambler-Osborn L, Anderson SM, Church MM, Ekhlaspour L, Forlenza GP, Levister C, Simha V, Breton MD, Kollman C, Lum JW, Kovatchev BP; iDCL Trial Research Group. Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial. Diabetes Care. 2020; 43(8):1822-1828. PMID: 32471910
- 9. Deshpande S, Pinsker JE, Church M, Piper M, Andre C, Massa J, Doyle III FJ, Eisenberg DM, Dassau E. Randomized Crossover Comparison of Automated Insulin Delivery vs. Conventional Therapy using an Unlocked Smartphone with Scheduled Pasta and Rice Meal Challenges in the Outpatient Setting. Diabetes Technol Ther. 2020; 22(12):865-874. PMID: 32319791
- 10. Kovatchev B, Anderson SM, Raghinaru D, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, Buckingham BA, Doyle III FJ, Brown SA, Church M, Dadlani V, Dassau E, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Beck RW, for the iDCL Study Group. Randomized Controlled Trial of Mobile Closed-Loop Control. Diabetes Care. 2020; 43(3):607-615. PMID: 31937608